⌘K
Loading ticker…
As of 2026-08-24, Entrada Therapeutics, Inc. Common Stock (TRDA) has a 3-month relative strength percentile of 70 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 48. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.3%, relative volume 0.52×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
TRDA is held by 18 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $1M notional. Top 3 carry $2M.
Held by 36 ETFs · $36M across latest filings · largest weight 0.31% (IBRN).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $1M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.00% | $802K | — |
| AVSC | 0.02% | $491K | −0.01 pp |
| VHTVanguard Health Care ETF | 0.00% | $404K | — |
| GSSC | 0.02% | $234K | −0.02 pp |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.01% |
| $160K |
| — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $122K | — |
| AVUSAvantis U.S. Equity ETF | 0.00% | $49K | — |
| IBBQ | 0.02% | $14K | −0.01 pp |
| VTHRVanguard Russell 3000 ETF | 0.00% | $14K | — |
Showing 10 of 18 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TRDA Jan avg: -6.14% median: -6.79% win: 25% σ: 13.99% n: 4 2022-04-12 → 2026-07-31 | TRDA Feb avg: -2.78% median: -2.46% win: 50% σ: 8.58% n: 4 2022-04-12 → 2026-07-31 | TRDA Mar avg: 0.58% median: 6.44% win: 75% σ: 16.94% n: 4 2022-04-12 → 2026-07-31 | TRDA Apr avg: -7.76% median: -11.14% win: 40% σ: 11.30% n: 5 2022-04-12 → 2026-07-31 | TRDA May avg: -4.59% median: -2.14% win: 40% σ: 29.80% n: 5 2022-04-12 → 2026-07-31 | TRDA Jun avg: 19.38% median: 4.10% win: 60% σ: 38.06% n: 5 2022-04-12 → 2026-07-31 | TRDA Jul avg: 3.03% median: 5.09% win: 60% σ: 12.80% n: 5 2022-04-12 → 2026-07-31 | TRDA Aug avg: -4.02% median: -4.15% win: 25% σ: 9.56% n: 4 2022-04-12 → 2026-07-31 (current) | TRDA Sep avg: 7.11% median: 6.69% win: 75% σ: 14.10% n: 4 2022-04-12 → 2026-07-31 | TRDA Oct avg: 18.26% median: 13.54% win: 100% σ: 19.19% n: 4 2022-04-12 → 2026-07-31 | TRDA Nov avg: 2.63% median: -1.47% win: 50% σ: 36.74% n: 4 2022-04-12 → 2026-07-31 | TRDA Dec avg: -1.58% median: -4.79% win: 50% σ: 13.19% n: 4 2022-04-12 → 2026-07-31 |